3386.0 Across the Drug Spectrum: From Research to Evaluation to Integration

Monday, October 29, 2012: 4:30 PM - 5:30 PM
Linda Joy Frazier, MA, RN, MCHES

Board 1
Consumer participation in the development of a manualized behavioral treatment for chronic pain in a methadone population
Kristen Rosen, MPH, Elise Marino, Michael Fitzpatrick and Jennifer Potter, PhD
Board 2
Factors that contribute to participation in clinical trials
Lynn Kunkel, MS, CCRP, Aisha Kudura, MPH, Dennis McCarty, PhD and Michele Straus, RPh, MS
Board 3
Translating population-based smoke-free policy concerns into a pair-based tobacco cessation intervention: A multi-staged formative approach for developing a novel intervention
Elisa Tong, MD, Debora A. Paterniti, PhD, Lei-Chun Fung, MPH, MSW, Moon S. Chen, PhD, MPH, Leonard Tam, Carrie Tang, Chin-Shang Li, PhD and Janice Tsoh, PhD
Board 4
Drug Treatment Outcomes Using the Matrix Model in an Outpatient Setting with Minority Clients
Grace L. Reynolds, DPA, Bridget Rogala, MPH, MCHES and Dennis G. Fisher, PhD
Board 8
How the news media frames the debate over alcohol taxes
Samantha Cukier, MBA, MA, Rebecca Reynolds-Ramirez, MPH, Katherine Clegg Smith, PhD and David H. Jernigan, PhD
Board 9
Using multiple recruiting sources to reach untapped segments of the recovery community in research
Alexandre Laudet, PhD, Lee Ann Kaskutas, DrPH, Thomassina Borkman, PhD, Lois Ritter, PhD and M.N. Subbaraman

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs